Cite
HARVARD Citation
Klaschik, K. et al. (2019). The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers. International journal of cancer. 144 (7), pp. 1761-1763. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Klaschik, K. et al. (2019). The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers. International journal of cancer. 144 (7), pp. 1761-1763. [Online].